AR006308A1 - Sistema dispensador; un metodo para estabilizar una composicion; una composicion acuosa y el uso del sistema dispensador. - Google Patents
Sistema dispensador; un metodo para estabilizar una composicion; una composicion acuosa y el uso del sistema dispensador.Info
- Publication number
- AR006308A1 AR006308A1 ARP970100422A ARP970100422A AR006308A1 AR 006308 A1 AR006308 A1 AR 006308A1 AR P970100422 A ARP970100422 A AR P970100422A AR P970100422 A ARP970100422 A AR P970100422A AR 006308 A1 AR006308 A1 AR 006308A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- biologically effective
- effective compound
- dispensing system
- aqueous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
- B05B11/1081—Arrangements for pumping several liquids or other fluent materials from several containers, e.g. for mixing them at the moment of pumping
- B05B11/1084—Arrangements for pumping several liquids or other fluent materials from several containers, e.g. for mixing them at the moment of pumping each liquid or other fluent material being pumped by a separate pump
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un sistemas dispensador que permite la aplicación de una composición acuosa que contiene un compuesto biológicamente efectivo estabilizadoadecuadamente. Se utiliza un sistema dispensador de dos cámaras en donde están contenidas de forma sseparada una composición que comprende uncompuesto biológicamente efectivo y una composición básica acuosa. El sistema dispensador entrega ambas composiciones simultáneamente, con lo cual lascomposiciones se mezclan para dar como resultado una composición final adecuada para una aplicación directa, de dicho compuesto biológicamenteefectivo en su forma activa. La primer y segunda composición se entregan en una relación que varía de 1:1 a 1:50. Adicionalmente la composición puedec omprenderotro ingrediente activo. También puede contener agentes para aumentar la viscosidad. El compuesto biológicamente activo son inestablesen la formulación acuosa final en la cual se debería aplicar. Preferentemente dichos compuestos pueden ser enzimas,antibióticos, vitaminas,dihidroxiacetonas, etc. Se refiere también a un método para estabilizar físicamente una composición que comprende adicionar un agente para aumentarla viscosidad a la composición de un compuesto biol ógicamente efectivoformulado en forma de partículas. Otro objeto es una composición acuosaque comprende el compuesto biológicamente efectivo. Finalmente describe el uso del sistema dispensador para el empleo de aplicaciones tópicas del compuesto biológicamenteefectivo.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96200190 | 1996-01-31 | ||
EP96200594 | 1996-03-08 | ||
EP96201713 | 1996-06-21 | ||
EP96202781 | 1996-10-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR006308A1 true AR006308A1 (es) | 1999-08-25 |
Family
ID=27443289
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970100422A AR006308A1 (es) | 1996-01-31 | 1997-02-03 | Sistema dispensador; un metodo para estabilizar una composicion; una composicion acuosa y el uso del sistema dispensador. |
Country Status (16)
Country | Link |
---|---|
US (1) | US6117433A (es) |
EP (1) | EP0817613B1 (es) |
JP (1) | JPH11503465A (es) |
KR (1) | KR100517060B1 (es) |
CN (1) | CN1140261C (es) |
AR (1) | AR006308A1 (es) |
AT (1) | ATE291897T1 (es) |
AU (1) | AU1721697A (es) |
BR (1) | BR9702049B1 (es) |
CA (1) | CA2216169C (es) |
DE (1) | DE69732881T2 (es) |
ES (1) | ES2237789T3 (es) |
ID (1) | ID18666A (es) |
MX (1) | MX9707487A (es) |
PT (1) | PT817613E (es) |
WO (1) | WO1997027841A1 (es) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5947335A (en) * | 1996-10-15 | 1999-09-07 | Lever Brothers Company | Dual compartment package |
US6082588A (en) * | 1997-01-10 | 2000-07-04 | Lever Brothers Company, Division Of Conopco, Inc. | Dual compartment package and pumps |
EP0996428A2 (en) | 1997-07-08 | 2000-05-03 | Dsm N.V. | Topical application of a combination of benzoyl peroxide and a second active ingredient |
KR100351620B1 (ko) * | 1999-07-09 | 2002-09-10 | 주식회사대성미생물연구소 | 3차 결정구조의 내열성 효소 |
KR100340086B1 (ko) * | 1999-08-27 | 2002-06-12 | 안용찬 | 비듬방지용 샴푸조성물 |
US6585984B1 (en) * | 2000-03-03 | 2003-07-01 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Dual composition cosmetic product with a concentration sensitive and an incompatible active respectively placed within first and second compositions |
AU2001255487A1 (en) * | 2000-04-21 | 2001-11-07 | Nature's Cure | Salicylic acid acne spray formulations and methods for treating acne with same |
US20030206897A1 (en) * | 2000-09-13 | 2003-11-06 | The Procter & Gamble Company | Cosmetic compositions |
EP1317246A1 (en) * | 2000-09-13 | 2003-06-11 | The Procter & Gamble Company | Cosmetic method |
MXPA03002170A (es) * | 2000-09-13 | 2003-07-24 | Procter & Gamble | Composiciones cosmeticas. |
MXPA03002166A (es) * | 2000-09-13 | 2003-07-24 | Procter & Gamble | Metodo cosmetico para tratar la piel y/o el cabello. |
AU2000274825A1 (en) * | 2000-09-13 | 2002-03-26 | The Procter And Gamble Company | Cosmetic method |
AU2000274826A1 (en) * | 2000-09-13 | 2002-03-26 | The Procter And Gamble Company | Cosmetic compositions |
JP2002326924A (ja) * | 2001-05-07 | 2002-11-15 | Hayashibara Biochem Lab Inc | 洗顔料 |
US7364565B2 (en) | 2001-07-27 | 2008-04-29 | Ramot At Tel Aviv University Ltd. | Controlled enzymatic removal and retrieval of cells |
CA2465068A1 (en) * | 2001-11-03 | 2003-05-15 | Astrazeneca Ab | Quinazoline derivatives as antitumor agents |
GB0126433D0 (en) * | 2001-11-03 | 2002-01-02 | Astrazeneca Ab | Compounds |
US20080152722A1 (en) * | 2002-01-31 | 2008-06-26 | Norburn Robert B | Skin care composition |
US20080152613A1 (en) * | 2002-01-31 | 2008-06-26 | Norburn Robert B | Method for manufacturing a skin care composition |
CA2416305A1 (en) * | 2002-01-31 | 2003-07-31 | Davies, John | Shaving, after-shave, and skin conditioning compositions |
TWI324597B (en) * | 2002-03-28 | 2010-05-11 | Astrazeneca Ab | Quinazoline derivatives |
US6924285B2 (en) | 2002-03-30 | 2005-08-02 | Boehringer Ingelheim Pharma Gmbh & Co. | Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
FR2840215B1 (fr) * | 2002-06-03 | 2004-08-27 | Oreal | Composition contenant un actif susceptible d'etre oxyde par un hydroperoxyde, une lipoxygenase et un substrat et procede mettant en oeuvre cette composition |
DE10241073A1 (de) * | 2002-09-05 | 2004-03-11 | Beiersdorf Ag | Kosmetikum mit aktivierbaren Pflegekomponenten |
GB0309009D0 (en) * | 2003-04-22 | 2003-05-28 | Astrazeneca Ab | Quinazoline derivatives |
GB0309850D0 (en) * | 2003-04-30 | 2003-06-04 | Astrazeneca Ab | Quinazoline derivatives |
DE602004023796D1 (de) * | 2003-08-20 | 2009-12-10 | Seikagaku Kogyo Co Ltd | Stabilisierungsmittel für Enzyme |
DE10342211A1 (de) * | 2003-09-12 | 2005-04-07 | Beiersdorf Ag | Kosmetikum |
GB0321648D0 (en) * | 2003-09-16 | 2003-10-15 | Astrazeneca Ab | Quinazoline derivatives |
JP2007505873A (ja) * | 2003-09-16 | 2007-03-15 | アストラゼネカ アクチボラグ | チロシンキナーゼ阻害剤としてのキナゾリン誘導体 |
DE602004004811T2 (de) * | 2003-09-19 | 2007-11-22 | Astrazeneca Ab | Chinazolinderivate |
DK1667992T3 (da) * | 2003-09-19 | 2007-04-30 | Astrazeneca Ab | Quinazolinderivater |
US20070043010A1 (en) * | 2003-09-25 | 2007-02-22 | Astrazeneca Uk Limited | Quinazoline derivatives |
ATE548127T1 (de) * | 2003-10-03 | 2012-03-15 | Kao Corp | Abführvorrichtung |
SI1673057T1 (sl) * | 2003-10-10 | 2009-10-31 | Cosmedical Aps | Inhibitor rasti dlak |
EP1677747A1 (en) * | 2003-10-31 | 2006-07-12 | The Procter & Gamble Company | Method of providing a blended composition |
GB0326459D0 (en) * | 2003-11-13 | 2003-12-17 | Astrazeneca Ab | Quinazoline derivatives |
BRPI0511741A (pt) * | 2004-06-04 | 2008-01-02 | Astrazeneca Ab | derivado de quinazolina ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, processo para a preparação de um derivado de quinazolina ou de um sal farmaceuticamente aceitável do mesmo |
JP2005350384A (ja) * | 2004-06-09 | 2005-12-22 | Blc:Kk | 基礎化粧方法 |
CA2578250C (en) | 2004-07-26 | 2013-03-05 | Merz Pharma Gmbh & Co. Kgaa | Therapeutic composition with a botulinum neurotoxin |
JP4881875B2 (ja) | 2004-12-14 | 2012-02-22 | アストラゼネカ アクチボラグ | 抗腫瘍剤としてのピラゾロピリミジン化合物 |
UY29398A1 (es) * | 2005-02-26 | 2006-10-02 | Astrazeneca Ab | Derivados de quinazolinas, sussales farmacéuticamente aceptables, composiciones que los contienen, procedimientos de preparación y aplicacións. |
GB0504474D0 (en) * | 2005-03-04 | 2005-04-13 | Astrazeneca Ab | Chemical compounds |
GB0508715D0 (en) * | 2005-04-29 | 2005-06-08 | Astrazeneca Ab | Chemical compounds |
GB0508717D0 (en) * | 2005-04-29 | 2005-06-08 | Astrazeneca Ab | Chemical compounds |
US7378084B2 (en) * | 2005-07-01 | 2008-05-27 | Playtex Products, Inc. | Sunless tanning composition and method of sunless tanning |
EP1931362A2 (en) * | 2005-08-10 | 2008-06-18 | Maya-Biotech Ltd. | Drug delivery system for topical administration |
ES2354457T3 (es) * | 2005-09-20 | 2011-03-15 | Astrazeneca Ab | Compuestos de 4-(1h-indazol-5-il-amino)-quinazolina como inhibidores del receptor erbb de la tirosina quinasa para el tratamiento del cáncer. |
EP1940825A1 (en) * | 2005-09-20 | 2008-07-09 | Astra Zeneca AB | Quinazoline derivatives as anticancer agents |
JP2009517450A (ja) * | 2005-12-02 | 2009-04-30 | アストラゼネカ アクチボラグ | チロシンキナーゼ阻害薬としての4−アニリノ置換キナゾリン誘導体 |
DE602006009304D1 (de) * | 2005-12-02 | 2009-10-29 | Astrazeneca Ab | Chinazoleinderivate |
EP1921070A1 (de) * | 2006-11-10 | 2008-05-14 | Boehringer Ingelheim Pharma GmbH & Co. KG | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung |
CA2677336A1 (en) * | 2007-02-06 | 2008-08-14 | Boehringer Ingelheim International Gmbh | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof |
US8569221B2 (en) * | 2007-08-30 | 2013-10-29 | Kimberly-Clark Worldwide, Inc. | Stain-discharging and removing system |
US8497369B2 (en) * | 2008-02-07 | 2013-07-30 | Boehringer Ingelheim International Gmbh | Spirocyclic heterocycles medicaments containing said compounds, use thereof and method for their production |
CA2723989C (en) * | 2008-05-13 | 2017-04-25 | Astrazeneca Ab | Fumarate salt of 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(n-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline |
WO2010015522A1 (de) * | 2008-08-08 | 2010-02-11 | Boehringer Ingelheim International Gmbh | Cyclohexyloxy-substituierte heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
WO2011133219A1 (en) * | 2010-04-21 | 2011-10-27 | Pharmacline, Llc | Topical drug delivery system with dual carriers |
EP2886163A1 (en) | 2011-12-20 | 2015-06-24 | Oriflame Research and Development Ltd. | Compounds with Anti-aging activities |
US9931657B2 (en) * | 2014-04-18 | 2018-04-03 | The Clorox Company | Dual chamber spray dispenser with a single delivery tube |
CN107245481B (zh) * | 2016-02-16 | 2018-06-01 | 上海青瑞食品科技有限公司 | 一种液体酶制剂及制备方法 |
EP3210630A1 (en) | 2016-02-29 | 2017-08-30 | G.L. Pharma GmbH | Abuse-deterrent pharmaceutical compositions |
EP3231420A1 (en) | 2016-02-29 | 2017-10-18 | G.L. Pharma GmbH | Abuse-deterrent pharmaceutical compositions |
EP3210596A1 (en) | 2016-02-29 | 2017-08-30 | G.L. Pharma GmbH | Abuse-deterrent pharmaceutical composition |
FR3052035B1 (fr) | 2016-06-02 | 2020-10-09 | Oreal | Systeme de distribution d'un produit cosmetique |
CN110494116A (zh) | 2017-03-27 | 2019-11-22 | 赢创德固赛有限公司 | 用于制备含神经酰胺的配制物的方法和产品 |
WO2018182252A1 (ko) * | 2017-03-31 | 2018-10-04 | 주식회사 아모레퍼시픽 | 아멘토플라본의 안정도가 향상된 투명 또는 반투명 화장료 조성물 |
AU2018255972A1 (en) | 2017-04-21 | 2019-10-31 | Phi Therapeutics, Inc. | Compositions comprising propionibacterium acnes bacteriophages for treating acne |
IT201900006994A1 (it) * | 2019-05-20 | 2020-11-20 | Biodermol Ambiente S R L | Ceppi batterici per uso industriale |
CA3159021A1 (en) * | 2019-11-22 | 2021-05-27 | So Jin Lee | Kit for preparing nanoparticle composition for drug delivery |
KR20230029260A (ko) * | 2021-08-24 | 2023-03-03 | (주)아모레퍼시픽 | 효소 손상을 방지하는 화장료 조성물 및 이를 저장하는 화장품 용기 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR6318M (es) * | 1967-04-04 | 1968-09-23 | ||
FR2032202A5 (es) * | 1969-02-21 | 1970-11-20 | Oreal | |
US3834075A (en) * | 1973-02-12 | 1974-09-10 | Tre X Injector Syst Co | Tree trunk pressure feeding device |
US3992813A (en) * | 1975-07-07 | 1976-11-23 | Freshel David C | Tree treating system |
US4243543A (en) * | 1979-05-11 | 1981-01-06 | Economics Laboratory, Inc. | Stabilized liquid enzyme-containing detergent compositions |
US4556554A (en) * | 1981-06-01 | 1985-12-03 | Germaine Monteil Cosmetiques Corp. | Immobilized enzymes |
AU3667189A (en) * | 1988-06-23 | 1990-01-04 | Unilever Plc | Enzyme-containing liquid detergents |
US4959179A (en) * | 1989-01-30 | 1990-09-25 | Lever Brothers Company | Stabilized enzymes liquid detergent composition containing lipase and protease |
WO1991000094A1 (en) * | 1989-06-28 | 1991-01-10 | Finn Tranberg | A new papaverine injection system |
JPH05502584A (ja) * | 1989-12-21 | 1993-05-13 | ノボ ノルディスク アクティーゼルスカブ | 酵素含有調製品及び該調製品を含有する洗剤 |
DE4023601A1 (de) * | 1990-07-25 | 1992-01-30 | Henkel Kgaa | Fluessige enzymzubereitung |
DE4121820A1 (de) * | 1991-07-02 | 1993-01-07 | Basf Ag | Mikrokapseldispersionen |
TW203552B (en) * | 1992-02-18 | 1993-04-11 | J Baroody Lloyd | Compositions of clindamycin and benzoyl peroxide for acne treatment |
US5252312A (en) * | 1992-09-30 | 1993-10-12 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Package effervescible composition |
DE69410259T2 (de) * | 1993-03-31 | 1998-10-01 | Schering Plough Healthcare | Sonnenlose bräunungsmethode und -apparat |
EP0731834B1 (en) * | 1993-12-03 | 2000-05-24 | Buckman Laboratories International, Inc. | Enzyme stabilization by block-copolymers |
US5843409A (en) * | 1994-08-08 | 1998-12-01 | Colgate Palmolive Company | Two component dentifrice for the treatment of dentinal hypersensitivity |
FR2725897B1 (fr) * | 1994-10-24 | 1996-12-06 | Oreal | Produit pour application topique contenant une lipase et un precurseur d'actif |
-
1997
- 1997-01-31 WO PCT/EP1997/000507 patent/WO1997027841A1/en active IP Right Grant
- 1997-01-31 EP EP97904378A patent/EP0817613B1/en not_active Expired - Lifetime
- 1997-01-31 JP JP9527321A patent/JPH11503465A/ja not_active Ceased
- 1997-01-31 ID IDP970303A patent/ID18666A/id unknown
- 1997-01-31 PT PT97904378T patent/PT817613E/pt unknown
- 1997-01-31 AT AT97904378T patent/ATE291897T1/de not_active IP Right Cessation
- 1997-01-31 KR KR1019970706871A patent/KR100517060B1/ko not_active IP Right Cessation
- 1997-01-31 CA CA002216169A patent/CA2216169C/en not_active Expired - Fee Related
- 1997-01-31 CN CNB971900523A patent/CN1140261C/zh not_active Expired - Fee Related
- 1997-01-31 BR BRPI9702049-4A patent/BR9702049B1/pt not_active IP Right Cessation
- 1997-01-31 US US08/930,685 patent/US6117433A/en not_active Expired - Lifetime
- 1997-01-31 AU AU17216/97A patent/AU1721697A/en not_active Abandoned
- 1997-01-31 ES ES97904378T patent/ES2237789T3/es not_active Expired - Lifetime
- 1997-01-31 DE DE69732881T patent/DE69732881T2/de not_active Expired - Lifetime
- 1997-01-31 MX MX9707487A patent/MX9707487A/es not_active IP Right Cessation
- 1997-02-03 AR ARP970100422A patent/AR006308A1/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ES2237789T3 (es) | 2005-08-01 |
ID18666A (id) | 1998-04-30 |
MX9707487A (es) | 1997-11-29 |
US6117433A (en) | 2000-09-12 |
EP0817613B1 (en) | 2005-03-30 |
CN1140261C (zh) | 2004-03-03 |
PT817613E (pt) | 2005-06-30 |
CA2216169A1 (en) | 1997-08-07 |
JPH11503465A (ja) | 1999-03-26 |
KR100517060B1 (ko) | 2006-05-25 |
CA2216169C (en) | 2007-01-23 |
KR19980703467A (ko) | 1998-11-05 |
EP0817613A1 (en) | 1998-01-14 |
ATE291897T1 (de) | 2005-04-15 |
BR9702049A (pt) | 1998-01-13 |
WO1997027841A1 (en) | 1997-08-07 |
DE69732881D1 (de) | 2005-05-04 |
DE69732881T2 (de) | 2006-04-06 |
CN1178460A (zh) | 1998-04-08 |
BR9702049B1 (pt) | 2010-08-10 |
AU1721697A (en) | 1997-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR006308A1 (es) | Sistema dispensador; un metodo para estabilizar una composicion; una composicion acuosa y el uso del sistema dispensador. | |
BR9810985A (pt) | Aplicação tópica de uma combinação de peróxido de benzoìla e um segundo ingrediente ativo | |
BR0008590A (pt) | Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto | |
MX9202407A (es) | Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion. | |
EA200501107A1 (ru) | Фармацевтические и/или косметические системы дозирования для местного применения | |
PT2455083E (pt) | Composição farmacêutica para aplicação dérmica compreendendo calcipotriol e betametasona para o tratamento da psoríase | |
GR3006146T3 (es) | ||
ATE311373T1 (de) | Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen | |
ES2134359T3 (es) | Composiciones viscoelasticas de compuestos organicos fluorados. | |
BR9809057A (pt) | Composições antitussìgenas | |
AU607496B2 (en) | Pharmaceutical compositions | |
ATE253820T1 (de) | Wirkstoffhaltige komposition sowie deren herstellung und verwendung | |
KR900013964A (ko) | 활성형 비타민 d₃류 제제용 조성물 및 이를 함유하는 안정한 활성형 비타민 d₃류 제제의 제조방법 | |
AR012217A1 (es) | Una composicion topica para mejorar la penetracion de compuestos farmaceuticos | |
ES2134237T3 (es) | Composiciones farmaceuticas que contienen acido ursodesoxicolico. | |
ES2178131T3 (es) | Composicion cosmetica de esmalte a base de nitrocelulosa que contiene un agente estabilizante. | |
SE9403389D0 (sv) | Pharmaceutical composition containing derivattves of sex hormones | |
ES2083871T3 (es) | Composicion para la aplicacion topica. | |
GEP20053581B (en) | Pharmaceutical Composition and Method for Preparation Thereof | |
WO2001003774A3 (en) | Pharmaceutical composition for the treatment of calcification | |
EP0992242A4 (en) | PROPHYLACTIC AGENTS AND / OR REMEDIES CONTAINING VITAMIN D FOR PREVENTING AND / OR TREATING CONJUNCTIVAL / CORNEAL XEROSIS | |
TH33982A (es) | ||
DE69834434D1 (de) | Verbindung und Arzneizusammensetzung zur Verabreichung von Wirkstoffen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |